Introduction
Native and synthetic quinazoline derivatives are some of the priority objects of investigation in current organic and pharmaceutical chemistry. A lot of attention over the mentioned class of compounds caused by the broad potential of its chemical modification is aimed at the synthesis of the novel perspective potential medications [1] [2] [3] [4] . Recent publications describe the synthesis and biological activity of the [1, 2, 4] triazino [2,3-c] quinazoline series [5] [6] [7] [8] [9] [10] [11] [12] [13] . It is known that the introduction of a thio-group in position 6 of the [1, 2, 4] triazino [2,3-c] quinazoline system allows the obtainment of compounds with significant cytotoxic action against Photobacterium leiognathi [9, [11] [12] [13] and antimicrobial action against Staphyloccocus aureus and Aspergillus niger [8] [9] [10] [11] [12] [13] . The following structure modification of 6-thio-3-R-2H- [1, 2, 4] triazino [2,3-c] quinazoline-2-ones by synthesis of S-substituted derivatives enabled the obtainment of compounds with anticancer action [9, [11] [12] [13] . Authors noted that the above-mentioned type of action depends substantially on the nature of the pharmacophore fragment in positions 3 and 6. Adhering to the previously developed strategies of the target synthesis of chemotherapeutic agents, we decided to realize further structure modifications of 6-thio-3-R-2H- [1, 2, 4] triazino[2,3-c]-quinazoline-2-ones by the introduction of halogen and methyl substituents in positions 8, 9, 10 and study the antibacterial and antifungal activities of the synthesized compounds. Thus, this work aimed to study the influence of substituents (alkyl and halogen groups) in 6-R-3-(2-aminophenyl)-2H- [1, 2, 4] triazin-5-ones on the cyclocondensation process and on the antibacterial and antifungal activities of the synthesized compounds.
Results and Discussion

Chemistry
As starting compounds we used 6-R-3-(3-R 1 -4-R 2 -5-R 3 -2-aminophenyl)-1,2,4-triazin-5-ones (1.1-1.26) , which were obtained according to known protocols, namely by nucleophilic cleavage of the pyrimidine fragment in 3-R-8-R 1 -9-R 2 -10-R 3 -2H- [1, 2, 4] triazino [2,3-c] quinazolin-2-ones or hydrazinolysis of 2-aryl- [(3H-quinazolin-4-ylidene) hydrazono]acetic acids esters [14] . Synthesis of potassium thiolates 2.1-2.26 was performed by the interaction of initial compounds 1.1-1.26 with sulfur disulfide, ethanol, and potassium hydroxide in ethanol (Method A) or potassium O-ethyl dithiocarbonate in 2-propanol [8] 1.1-1.26 (Method В, Scheme 1). The products of the mentioned cyclocondensation were the individual compounds 2.1-2.26 with yields of 64-99%. Method B had some advantages: ease of execution, health safety, high yields, and purity of the final products. To prove the structure, the synthesized thiolates 2.1-2.26 were transformed in the corresponding thions 3.1-3.26 by acidifying the water solutions of the mentioned potassium salts with hydrochloric acid to pH 2-3. We noted that the substituents in positions 3, 4, and 5 in the corresponding 6-R-3-(2-aminophenyl)-1,2,4-triazino-5-ones (1.1-1.26) significantly affected the reaction process. So, according to LC-MS (APCI), the initial compounds, which contained the substituents chlorine, bromine, or iodine that were needed, increased the duration of heating to 8-10 hours. 
Sch. 1.
Synthesis of the potassium 3-R-8-R 1 -9-R 2 -10-R 3 -2-oxo-2H- [1, 2, 4] triazino[2,3-c]-quinazoline-6-thiolates 2.1-2.26 and 3-R-8-R 1 -9-R 2 -10-R 3 -6-thioxo-6,7-dihydro-2H- [1, 2, 4] triazino [2,3-c] quinazolin-2-ones 3.1-3.26
The purity of the synthesized compounds was confirmed by LC-MS (APCI) data, and the structure by IR-, 1 H-, 13 C NMR-, mass-spectra, and elemental analysis. In the LC-MS (APCI) spectra of 3.1-3.26, the positive ions [M+1] and [M+3] (sulfur isotope) were observed. The value of the molecular mass coincided with the expected for the synthesized compounds. The mass-spectra (EI) of thiones 3.1-3.4, 3.8 had some traits and substantial differences from the other heteroaromatic sulfides. In this case, molecular ion fragmentation under the electron impact pass on the С(2)-С(3) and N(4)-N(5) bond followed by the elimination of the nitrile radical and formation of an ion with m/z 203 had the highest intensity (96.7-100%). The mentioned ion underwent cleavage with the elimination of S, SH, CNS, CHNS, and CNO fragments and formation of an ion with m/z 171, 170, 145, 144, 161 with the corresponding intensity.
Our attempt to record the NMR spectral data for potassium 8-R 1 -9-R 2 -10-R 3 -3-R-2-oxo-2Н- [1, 2, 4] triazino[2,3-с]quinazoline-6-thiolates in DMSO-d 6 , CDCl 3 , and D 2 O failed. We considered this as a consequence of the exchange processes, tautomeric transformations, and insufficient solubility. However, for the evaluation of the mentioned compound structure, we converted them into thiones 3.1-3.26 and recorded all of the necessary spectral data to prove their structures. So, as we considered, the confirmation of the structures 3.1-3.26 in combination with the IR and elemental analysis data, proved the structures of compounds 2.1-2.26.
The
1 H-NMR-spectra of compounds 3.1-3.26 are characterized by singlet signals of the thioamide group proton at 14.22-13.79 ppm and aromatic protons of the triazinoquinazoline system with corresponding chemical shifts [16] . The appearance at 171.05-168.79 ppm and 158.68-160.2 ppm of the characteristic signals of deshielded C-2 and C-6 carbons in the 13 С NMR-spectra of compounds 3.1, 3.3, 3.4, and 3.8 confirm the formation of the new heterocyclic system. Also in the 13 С NMR-spectra of the mentioned compounds, the signals of the corresponding aliphatic carbons are present. As we considered, the used physicochemical methods completely confirm the structure of the synthesized compounds.
The IR-spectra of compounds 3.1-3.26 are characterized by intensive absorption at 1767-1590 cm −1 , which correspond to vibrations of the С=S and С=О groups and substantially differentiate them from their initial compounds. At the same time in the IR-spectra of thiolates (2.1-2.26), the mentioned signals were subjected to the hypsochromic shift which may be explained by the formation of an ion bond. The vibrations of С=С bonds of the aromatic fragment at 1589-1468 cm −1 of the non-plate deforming vibrations of the =C-H bond at 850-666 cm −1 and intensive signals at 2960-2850 cm −1 , caused by the symmetric and asymmetric vibrations of CH 2 and CH 3 groups, are also present in the IR-spectra of the compounds 2.1-2.26 and 3.1-3.26. The IR-spectra of compounds, which contain halogen intensive signals of νС-F, νС-Cl, νС-Br, νС-I, are also present.
Tab. 1.
Antimicrobial activities of potassium 8- 
Antimicrobial Activities
Results of the conducted microbiological screening showed that 3-R-8-R 1 -9-R 2 -10-R 3 -6-thioxo-6,7-dihydro-2H- [1, 2, 4] triazino[2,3-c]quinazolin-2-ones (3.1-3.26) exhibit moderate inhibitory activity (MIC 50-100 µg/mL, Tab. 1) on the Escherichia coli strain (lower than Nitrofural (MIC 1.5 µg/mL), similar to Trimetoprim (MIC 50 µg/mL)).
It is important to note that potassium thiolates 2.1-2.26, as more water-soluble in most cases, are less active (MIC 100 µg/mL, Table 2 ). The antimicrobial activity of compounds 2.1-2.26 and 3.1-3.26 towards the strain of Pseudomonas aeruginosa is also moderate (MIC 50-100 µg/mL) and substantially inferior to the inhibitory action of Nitrofural (MIC 6.25 µg/mL, tables 1 and 2).
Tab. 2.
Antimicrobial activities 8- 
Experimental
Chemistry
General Methods
Melting points were determined in open capillary tubes and were uncorrected. The elemental analyses (C, H, N, S) were performed using the ELEMENTAR vario EL Cube analyzer (USA). Analyses were indicated by the symbols of the elements or functions within ±0.3% of the theoretical values. The IR spectra (4000-600 cm −1 ) were recorded on a Bruker ALPHA FT-IR spectrometer (Bruker Bioscience, Germany) using a module for measuring attenuated total reflection (ATR). The 1 H NMR spectra (400 MHz) and 13 C NMR spectra (100 MHz) were recorded on a Varian-Mercury 400 (Varian Inc., Palo Alto, CA, USA) spectrometer with TMS as the internal standard in DMSO-d 6 solution. The LC-MS were recorded using a chromato-mass spectrometric system which consisted of a highperformance liquid chromatograph «Agilent 1100 Series» (Agilent, Palo Alto, CA, USA) equipped with a diode-matrix and mass-selective detector «Agilent LC/MSD SL» (atmospheric pressure chemical ionization -APCI). The electron impact mass spectra (EI-MS) were recorded on a Varian 1200 L instrument at 70 eV (Varian, USA). The purity of all obtained compounds was checked by 1 H-NMR and LC-MS.
Substances 1.1-1.26 were synthesized according to the reported procedures [14] . Other starting materials and solvents were obtained from commercially available sources and used without additional purification. 3-methyl-2-oxo-2H-[1,2,4] triazino [2,3-c]quinazoline-6-thiolate (2.1) Yield: 73.5% (Method А), 84% (Method B), mp >320°C; IR (cm −1 ): 3407, 3290, 3063, 2984 , 2909 , 2842 , 1621 , 1566 , 1472 , 1430 , 1379 , 1337 , 1298 , 1264 , 1239 , 1210 , 1166 , 1150 Anal. Calcd for C 11 H 7 N 4 OSK: C, 46.79; H, 2.50; N, 19.84; S, 11.35; Found: C, 46.78; H, 2.50; N, 19.83; S, 11.35. Potassium 2-oxo-3-phenyl-2H-[1,2,4] triazino [2,3-c]quinazoline-6-thiolate (2.2) Yield: 75% (Method А), 93% (Method B), mp >320°C; IR (cm −1 ): 1620 , 1602 , 1570 , 1524 , 1493 , 1474 , 1463 , 1432 , 1371 , 1319 , 1296 , 1277 , 1253 , 1232 , 1171 , 1155 , 1077 , 1034 , 1001 Anal. Calcd for C 16 H 9 N 4 OSK: C, 55.79; H, 2.63; N, 16.27; S, 9.31; Found: C, 55.78; H, 2.65; N, 16.27; S, 9.31. Potassium 3-(4-methylphenyl)-2-oxo-2H-[1,2,4] triazino [2,3-c]quinazoline-6-thiolate (2.3) Yield: 77% (Method А), 77% (Method B), mp >320°C; IR (cm −1 ): 3079, 1620 , 1602 , 1570 , 1524 , 1477 , 1463 , 1433 , 1405 , 1371 , 1346 , 1320 , 1300 , 1278 , 1246 , 1233 , 1172 , 1112 , 1075 , 1035 , 1023 Anal. Calcd for C 17 H 11 N 4 OSK: C, 56.96; H, 3.09; N, 15.64; S, 8.95; Found: C, 56.94; H, 3.09; N, 15.65; S, 8.94. Potassium 3-(3,4-dimethylphenyl)-2-oxo-2Н-[1,2,4] triazino [2,3-с] 3054, 3021, 2962, 2916, 1660, 1644, 1626, 1602, 1568, 1537, 1524, 1475, 1432, 1393, 1369, 1347, 1295, 1274, 1254, 1232, 1185, 1167, 1126, 1078, 1013, 982, 950, 903, 890, 868, 849, 833, 756, 736, 713, 704, 688, 659 
Potassium 3-(4-ethylphenyl)-2-oxo-2Н-[1,2,4]triazino[2,3-с]quinazoline-6-thiolate (2.5)
Yield: 79% (Method B), mp >320°C; IR (cm −1 ): 3389, 3238, 2955, 2927, 1620, 1602, 1571, 1520, 1478, 1464, 1435, 1412, 1370, 1348, 1318, 1303, 1280, 1254, 1233, 1175, 1161, 1120, 1075, 1045, 1019, 984, 940, 881, 846, 761, 735, 697, 688, 674, 657, 641, 630 
Potassium 3-(4-isopropylphenyl)-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-thiolate (2.6)
Yield: 90% (Method B), mp >320°C; IR (cm −1 ): 3411, 3056, 2954, 2926, 2867, 1621, 1604, 1570, 1538, 1505, 1477, 1463, 1440, 1415, 1369, 1343, 1302, 1279, 1245, 1234, 1174, 1117, 1074, 1051, 986, 942, 870, 847, 780, 754, 694, 686, 674, 658, 643, 627 
Potassium 3-(4-tert-butylphenyl)-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-thiolate (2.7)
Yield: 67% (Method А), 78% (Method B), mp >320°C; IR (cm −1 ): 3563, 3405, 2963 , 2867 , 1627 , 1607 , 1574 , 1539 , 1509 , 1444 , 1412 , 1280 , 1269 , 1255 , 1233 , 1198 , 1179 , 1135 , 1075 
Potassium 3-(4-methoxyphenyl)-2-oxo-2Н-[1,2,4]triazino[2,3-с]quinazoline-6-thiolate (2.8)
Yield: 83% (Method А), 99% (Method B), mp >320°C; IR (cm −1 ): 2963 , 2904 , 2830 , 1650 , 1570 , 1536 , 1477 , 1439 , 1417 , 1343 , 1315 , 1297 , 1280 , 1261 , 1254 , 1232 , 1168 , 1133 , 1075 , 1029 , 1018 , 1008 Anal. Calcd for C 17 H 11 N 4 O 2 SK: C, 54.53; H, 2.96; N, 14.96; S, 8.56; Found: C, 54.53; H, 2.97; N, 14.95; S, 8.55 . [1, 2, 4] triazino [2,3-с]quinazoline-2-thiolate (2.9) Yield: 91% (Method B), mp >320°C; IR (cm −1 ): 2980 , 1636 , 1602 , 1571 , 1532 , 1512 , 1477 , 1435 , 1418 , 1344 , 1298 , 1233 , 1172 , 1155 , 1123 , 1075 , 1039 Anal. calcd. for C 18 H 13 N 4 O2SK: C, 55.65; H, 3.37; N, 14.42; S, 8.25; Found: C, 55.67; H, 3.36; N, 14.42; S, 8.24 . [1, 2, 4] triazino [2,3-с]quinazoline-6-thiolate (2.10) Yield: 86% (Method А), 94% (Method B), mp >320°C; IR (cm −1 ): 3352, 2965 , 1635 , 1599 , 1572 , 1532 , 1474 , 1435 , 1408 , 1370 , 1344 , 1294 , 1280 , 1231 , 1153 , 1131 , 1095 , 1071 , 1015 Anal. calcd. for C 16 H 8 FN 4 OSK: C, 53.02; H, 2.22; N, 15.46; S, 8.85; Found: C, 53.05; H, 2.21; N, 15.45; S, 8.84. Potassium 8-methyl-2-oxo-3-phenyl-2H-[1,2,4] triazino [2,3-c]quinazoline-6-thiolate (2.11) Yield: 91% (Method А), 94% (Method B), mp >320°C; IR (cm −1 ): 3350, 3049, 2965 , 2915 , 1636 , 1614 , 1599 , 1575 , 1532 , 1480 , 1443 , 1412 , 1364 , 1350 , 1291 , 1260 , 1241 , 1192 , 1179 , 1132 , 1097 , 1023 , 1001 Anal. calcd. for C 17 H 11 N 4 OSK: C, 56.96; H, 3.09; N, 15.63; S, 8.95; Found: C, 56.97; H, 3.09; N, 15.64; S, 8.95 .
Potassium 3-(4-ethoxyphenyl)-2-oxo-2Н-
Potassium 3-(4-fluorophenyl)-2-oxo-2Н-
Potassium 9-fluoro-2-oxo-3-phenyl-2H-[1,2,4]triazino[2,3-c]quinazoline-6-thiolate (2.12)
Yield: 81% (Method B); mp >320°C; IR (cm −1 ): 3187, 3124, 3079, 3059, 3010, 2967 , 1665 , 1516 , 1444 , 1315 , 1295 , 1261 , 1190 , 1171 , 1143 , 1104 , 1085 , 1034 , 1018 , 1001 Anal. calcd. for C 16 H 8 FN 4 OSK: C, 53.02; H, 2.22; N, 15.46; S, 8.85; Found: C, 53.06; H, 2.22; N, 15.44; S, 8.83 . [1, 2, 4] triazino [2,3-c]quinazoline-6-thiolate (2.13) Yield: 83% (Method А), 87% (Method B); mp >320°C; IR (cm −1 ): 3099, 3058, 3014, 2961 , 2925 , 1650 , 1625 , 1599 , 1557 , 1503 , 1433 , 1413 , 1392 , 1354 , 1294 , 1273 , 1237 , 1184 , 1166 , 1143 , 1103 , 1017 calcd. for C 16 H 7 F 2 N 4 OSK: C, 50.52; H, 1.85; N, 14.73; S, 8.43; Found: C, 50.56; H, 1.85; N, 14.72; S, 2, 4] triazino [2,3-c]quinazoline-6-thiolate (2.14) Yield: 83% (Method B); mp >320°C; IR (cm −1 ): 3082, 3010, 2963 , 2879 , 2774 , 1600 , 1574 , 1538 , 1504 , 1487 , 1435 , 1354 , 1168 , 1027 , 1014 calcd. for C 17 H 10 FN 4 O 2 SK: C, 52.03; H, 2.57; N, 14.28; S, 8.17; Found: C, 52.02; H, 2.56; N, 14.29; S, 2, 4] triazino [2,3-c]quinazoline-6-thiolate (2.15) Yield: 75% (Method А), 82% (Method B), mp >320°C; IR (cm −1 ): 3899, 3851, 3645, 3626, 3389, 1640 , 1625 , 1599 , 1558 , 1538 , 1493 , 1474 , 1449 , 1410 , 1346 , 1319 , 1278 , Sci Pharm. 2014 ; 82: 483-500 1251 , 1237 , 1174 , 1130 , 1094 , 1038 , 1004 Anal. calcd. for C 16 H 8 ClN 4 OSK: C, 50.72; H, 2.13; N, 14.79; S, 8.46; Found: C, 50.74; H, 2.13; N, 14.78; S, 8.45 . [1, 2, 4] triazino [2,3-с] quinazoline -6-thiolate (2.16) Yield: 90% (Method B); mp >320°C; IR (cm −1 ): 1624 , 1537 , 1475 , 1447 , 1407 , 1342 , 1278 , 1237 , 1186 , 1174 , 1133 , 1091 , 1059 , 1021 calcd. for C 17 H 10 ClKN 4 OS: C, 51.97; H, 2.57; N, 14.26; S, 8.16; Found: C, 51.94; H, 2.57; N, 14.28; S, 8.18 . [1, 2, 4] triazino [2,3-с] quinazoline -6-thiolate (2.17) Yield: 82% (Method B); mp >320°C; IR (cm −1 ): 3056, 2981 , 2942 , 2915 , 1649 , 1608 , 1596 , 1574 , 1541 , 1521 , 1503 , 1456 , 1394 , 1344 , 1271 , 1237 , 1150 , 1096 , 1017 Anal. calcd. for C 17 H 10 ClN 4 O 2 SK: C, 49.93; H, 2.46; N, 13.70; S, 7.84; Found: C, 49.97; H, 2.46; N, 13.68; S, 7.82. Potassium 10-chloro-3-(4-fluorophenyl)-2-oxo-2Н-[1,2,4] triazino [2,3-с]quinazoline-6-thiolate (2.18) Yield: 66% (Method А), 79% (Method B), mp >320°C; IR (cm −1 ): 1628 , 1598 , 1557 , 1539 , 1504 , 1474 , 1446 , 1403 , 1367 , 1341 , 1320 , 1299 , 1278 , 1237 , 1172 , 1157 , 1130 , 1100 , 1089 , 1065 , 1009 Anal. calcd. for C 16 H 7 ClFKN 4 OS: C, 48.42; H, 1.78; N, 14.12; S, 8.08; Found: C, 48.46; H, 1.78; N, 14.13; S, 8.10. Potassium 8-bromo-3-(4-fluorophenyl)-2-oxo-2Н-[1,2,4] triazino [2,3-с]quinazoline-6-thiolate (2.19) Yield: 86% (Method B), mp >320°C; IR (cm −1 ): 2954 , 1621 , 1593 , 1532 , 1504 , 1472 , 1446 , 1411 , 1383 , 1365 , 1311 , 1285 , 1271 , 1233 , 1218 , 1147 , 1112 , 1074 Anal. calcd. for C 16 H 7 BrFN 4 OSK: C, 43.54; H, 1.60; N, 12.70; S, 7.27; Found: C, 43.52; H, 1.61; N, 12.71; S, 7.28. Potassium 9-bromo-3-(4-fluorophenyl)-2-oxo-2Н-[1,2,4] triazino [2,3-с]quinazoline-6-thiolate (2.20) Yield: 99% (Method B); mp >320°C; IR (cm −1 ): 3390, 1632 , 1591 , 1557 , 1538 , 1455 , 1406 , 1372 , 1337 , 1288 , 1263 , 1232 , 1159 , 1102 , 1070 Anal. calcd. for C 16 H 7 BrFN 4 OSK: C, 43.54; H, 1.60; N, 12.70; S, 7.27; Found: C, 43.50; H, 1.60; N, 12.72; S, 7.22. Potassium 10-bromo-2-oxo-3-phenyl-2H-[1,2,4] triazino [2,3-c]quinazoline-6-thiolate (2.21) Yield: 65% (Method B); mp >320°C; IR (cm −1 ): 3149, 3097, 3057, 2979 , 2909 , 1657 , 1630 , 1614 , 1595 , 1555 , 1507 , 1474 , 1425 , 1342 , 1283 , 1260 , 1232 , 1190 , 1152 , 1120 , 1088 , 1034 , 1014 Anal. calcd. for C 16 H 8 BrN 4 OSK: C, 45.40; H, 1.90; N, 13.23; S, 7.57; Found: C, 45.44; H, 1.90; N, 13.22; S, 7.55. Potassium 10-bromo-3-(4-methylphenyl)-2-oxo-2H-[1,2,4] triazino [2,3-c]quinazoline-6-thiolate (2.22) Yield: 91% (Method B); mp >320°C; IR (cm −1 ): 1623 , 1537 , 1472 , 1444 , 1404 , 1369 , 1339 , 1322 , 1242 , 1185 , 1134 , 1080 , 1021 Anal. calcd. for C 17 H 10 BrN 4 OSK: C, 46.69; H, 2.30; N, 12.81; S, 7.33; Found: C, 46.65; H, 2.30; N, 12.83; S, 7.35. Potassium 10-bromo-3-(4-fluorophenyl)-2-oxo-2Н-[1,2,4] triazino [2,3-с] quinazoline -6-thiolate (2.23) Yield: 88% (Method B); mp >320°C; IR (cm −1 ): 1627 , 1596 , 1538 , 1504 , 1471 , 1444 , 1401 , 1369 , 1339 , 1277 , 1241 , 1158 , 1132 , 1077 , 1009 Anal. calcd. for C 16 H 7 BrFN 4 OSK: C, 43.54; H, 1.60; N, 12.70; S, 7.27; Found: C, 43.58; H, 1.60; N, 12.68; S, 7.25. Potassium 10-bromo-3-(4-methoxyphenyl)-2-oxo-2Н-[1,2,4] triazino [2,3-с]quinazoline-6-thiolate (2.24) Yield: 89% (Method B); mp >320°C; IR (cm −1 ): 3079, 3050, 3018, 2988 , 2930 , 2833 , 1622 , 1571 , 1555 , 1533 , 1511 , 1472 , 1444 , 1434 , 1409 , 1371 , 1339 , 1306 , 1271 , 1242 , 1133 , 1123 , 1112 , 1079 , 1009 [1, 2, 4] triazino [2,3-c] 3499, 3359, 1678 , 1628 , 1609 , 1590 , 1555 , 1538 , 1521 , 1487 , 1472 , 1444 , 1402 , 1374 , 1337 , 1327 , 1296 , 1241 , 1215 , 1172 , 1158 , 1126 , 1100 , 1074 , 1011 Anal. calcd. for C 16 H 7 FIN 4 OSK: C, 39.35; H, 1.44; N, 11.47; S, 6.57; Found: C, 39.39; H, 1.44; N, 11.45; S, 6.56. Potassium 10-iodo-3-(4-methoxyphenyl)-2-oxo-2Н-[1,2,4] triazino [2,3-с]quinazoline-6-thiolate (2.26) Yield: 90% (Method B); mp >320°C; IR (cm −1 ): 3080, 3051, 3020, 2971 , 2930 , 2834 , 1622 , 1590 , 1571 , 1532 , 1511 , 1472 , 1435 , 1421 , 1405 , 1338 , 1306 , 1139 , 1112 , 1078 Proper potassium 8-R 1 -9-R 2 -10-R 3 -3-R-2-oxo-2Н- [1, 2, 4] triazino[2,3-с]quinazolin-2-оnes (2) (10 mmol) was dissolved in 20 mL of water and acidified by the addition of hydrochloric acid to рН 2-3. The formed precipitate was filtered and dried. -6-thioxo-6,7-dihydro-2H-[1,2,4] triazino [2,3-c]quinazolin-2-one (3.1) Yield: 99%, mp 254-256°C; IR (см −1 ): 3118, 3056, 3029, 2954, 2917, 2849, 1767, 1743, 1687, 1637, 1616, 1594, 1564, 1519, 1471, 1455, 1421, 1381, 1360, 1322, 1303, 1277, 1257, 1225, 1169, 1128, 1111, 1039, 1025, 988, 949, 862, 771, 752, 716, 671, 655, 623; determined by the absence of growth on agar after inoculation of the microorganism from the transparent test tubes. Dimethylsulfoxide was used as a solvent, with an initial solution concentration of 1 mg/mL. Preliminary screening was performed on Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Candida albicans ATCC 885-653 standard test cultures. All test strains were received from the bacteriological laboratory Zaporizhzhya Regional Laboratory Center of State Sanitary and Epidemiological Service of Ukraine. Nitrofual and Trimetoprim were used as the reference compound with proven antibacterial/antifungal activity. Additional quality control of the culture medium and solvents was conducted by commonly used methods [17] .
Potassium 9-fluoro-3-(4-fluorophenyl)-2-oxo-2H-
Potassium 10-chloro-3-(4-methylphenyl)-2-oxo-2Н-
Potassium 10-chloro-3-(4-methoxyphenyl)-2-oxo-2Н-
Potassium 3-(4-fluorophenyl)-10-iodo-2-oxo-2H-
3-Methyl
Conclusion
In the present paper, 43 new 8-R 1 -9-R 2 -10-R 3 -3-R-6-thio-6,7-dihydro-2Н- [1, 2, 4] triazino-[2,3-с]quinazoline-2-оnes and their potassium salts were described. The synthesized compounds were tested for antibacterial and antifungal activity. As a result of the microbiological assay, the compounds with high inhibitory action against Staphylococcus aureus ATCC 25923 (MIC 6.25-100 µg/mL, МBC 12.5-200 µg/mL) were found.
